Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 6
Submit an article Journal homepage
29
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Thalidomide in Relapsed or Refractory Multiple Myeloma: How Much and for How Long?

Saad Habib Abdalla Imperial College Faculty of Medicine, St Mary's Campus, Norfolk Place London W2 1PG, UK
&
Sarah Mahmoud Haematology Oncology Pharmacist, St Mary's NHS Trust, Praed Street London W2 1NY, UK
Pages 989-991 | Published online: 01 Jul 2009

  • Singhal, S., Mehta, J., Desikan, R., Ayers, D., Roberson, P., Eddlemon, P., Munshi, N., Anaissie, E., Wilson, C., Dhodapkar, M., Zeddis, J. and Barlogie, B. (1999) "Antitumor activity of thalidomide in refractory multiple myeloma", New England Journal of Medicine 341, 1565-1571.
  • Juliusson, G., Celsing, F., Turesson, I., Lenhoff, S., Adriansson, M. and Malm, C. (2000) "Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma", British Journal of Haematology 109, 89-96.
  • Zomas, A., Anagnostopoulos, N. and Dimopoulos, M.A. (2000) "Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent", Bone Marrow Transplantation 25, 1319-1320.
  • Tosi, P., Ronconi, S., Zamagni, E., Cellini, C., Grafone, T., Cangini, D., Pileri, S.A., Baccarani, M., Tura, S. and Cavo, M. (2001) "Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation", Haematologica 86, 409-413.
  • Hus, M., Dmoszynska, A., Soroka-Wojtaszko, M., Jawnlak, D., Legiec, W., Ciepnuch, H., Hellmann, A., Wolska-Smolen, T., Skotnicki, A. and Manko, J. (2001) "Thalidomide treatment of resistant or relapsed multiple myeloma patients", Haematologica 86, 404-408.
  • Tosi, P., Zamagni, E., Cellini, C., Ronconi, S., Patriarca, F., Ballerini, F., Musto, P., Di Raimondo, F., Ledda, A., Lauria, F., Masini, L., Gobbi, M., Vacca, A., Ria, R., Cangini, D., Tura, S., Baccarani, M. and Cavo, M. (2002) "Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma", Haematologica 87, 408-414.
  • Yakouh-Agha, I., Attal, M., Dumontet C., Delannoy, V., Moreau, P., Berthou, C., Lamy, T., Grosbois, B., Dauriac, C., Dorvaux, V., Bay, J.O., Monconduit, M., Harousseau, J.L., Duguet, C., Duhamel, A. and Facon, T. (2000) "Thalidomide in patients with advanced multiple myeloma", Hematological Journal 1, 186-189.
  • Johnston, R.F., and Abdalla, S.H. (2002) "Thalidomide in low doses is effective for the treatment of resistant or relapsed multiple myeloma and for plasma cell leukaemia", Leukaemia and Lymphoma 43, 351-354.
  • Leleu, X., Magro, L., Fawaz, A., Bauters, F., Facon, T. and Yakoub-Agha, I. (2002) "Efficacy of a low dose of thalidomide in advanced multiple myeloma", Blood 100, 1519-1520.
  • Palumbo, A., Giaccone, L., Bertola, A., Pregno, P., Bringhea, S., Rus, C., Triolo, S., Gallo, E., Pileri, A. and Boccadoro, M. (2001) "Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advance myeloma", Haematologica 86, 399-403.
  • Pini, M., Baraldi, A., Pietrasanta, D., Allione, B., Depaoli, L., Salvi, F. and Levis, A. (2000) "Low-dose of thalidomide in the treatment of refractory myeloma", Haematologica 85, 1111-1112.
  • Lee, F.C. (2002) "Second response to lower-dose thalidomide in a patient with multiple myeloma", Blood 99, 4248.
  • Barlogie, B., Desikcan, R., Eddlemon, P., Spencer, T., Zeldis, J., Munshi, N., Badras, A., Zangari, M., Anaissie, E., Epstein, J., Shaughnessy, J., Ayers, D., Spoon, D. and Tricot, G. (2001) "Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients", Blood 98, 492-494.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.